The Intravenous Infusion Pumps Market to grow on the back of on-demand healthcare, witnessing a CAGR of 9%

Newly-released Intravenous Infusion Pumps market analysis report by Persistence Market Research shows that global sales of the Intravenous Infusion Pumps Market in 2021 were held at US$ 5.2 Bn. With a CAGR of 9% during 2022 - 2032, the market is projected to reach a valuation of US$ 13.2 Bn.

The absolute dollar opportunity for Intravenous Infusion Pumps Market will be witnessing US$ 7.6 Bn overall growth because the demand for intravenous infusion pumps in healthcare facilities such as hospitals, and nursing homes have significantly increased.

The intravenous (IV) infusion pumps market is a segment of the larger medical devices market, and is characterized by the use of pumps to deliver fluids, such as medications and nutrients, directly into a patient's vein. These devices are commonly used in hospitals, clinics, and other healthcare settings to administer a wide range of treatments, including chemotherapy, antibiotics, and pain management.

One major driver of the market is the increasing prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular disease, which often require long-term treatment with IV medications. Another driver is the aging population, as older individuals are more likely to require IV treatments due to their higher incidence of chronic conditions.

Companies

BAXTER INTERNATIONAL
B. BRAUN MELSUNGEN AG
MEDTRONIC
MICREL MEDICAL DEVICES SA
BOSTON SCIENTIFIC CORPORATION
CAREFUSION CORPORATION
FRESENIUS KABI
SMITHS MEDICAL

Get Free Sample Copy Of This Report To Understand The Structure Of The Complete Report@ https://www.persistencemarketresearch.com/samples/33220

Revenue of Intravenous Infusion Pumps Market from 2017 to 2021 Compared to Demand Outlook for 2022 to 2032

As per the Intravenous Infusion Pumps Market research by Persistence Market Research - a market research and competitive intelligence provider, historically, from 2017 to 2021, the market value of the Intravenous Infusion Pumps Market increased at around 7.6% CAGR, wherein, North America held significant share in the global market.

The prevalence of chronic diseases such as diabetes, cardiovascular disease, cancer, respiratory disease, and other autoimmune conditions has been increasing at a global level, spurring significant growth in the Intravenous Infusion Pumps Market. According to the World Health Organization (WHO), by 2030, the population of people aged 60 and above is forecasted to reach 1.4 billion, which will further drive demand for infusion pumps. These devices are commonly used in surgical and medical procedures, thereby propelling the growth of this market segment.

Moreover, advancements in technology have helped create innovative intravenous infusion pumps that are capable of providing greater safety and accuracy in delivering medication or fluids into a patient's body; this feature has become increasingly important given the complexity of many chronic diseases. Furthermore, as prevention becomes increasingly preferred over treatment for many conditions, improved accuracy and precision of these devices can help healthcare professionals accurately monitor patients' vital signs so that any adverse reactions to medication or fluids can be quickly addressed. Additionally, innovation within the field has seen an increase in features such as wireless connectivity and automated control systems which enable remote monitoring and control of IV pumps from a single device. All these developments have contributed to increased adoption rates which will lead to more growth opportunities for this industry segment.

Chronic illnesses are an increasingly prominent contributor to disability and mortality across the world, with around 80% of all deaths in lower- and middle-income countries linked to chronic conditions. These illnesses include cardiovascular diseases, stroke, cancer, chronic respiratory diseases, and diabetes. Of these conditions, cardiovascular disease is the most common cause of death globally according to the World Health Organization.

Cardiovascular disease can refer to any number of conditions related to the heart or blood vessels, including coronary artery disease that leads to heart attacks or strokes due to blockages in these vessels caused by fatty deposits known as plaque buildup. Cancer is a group of malignant diseases that cause cells in different organs or tissues of the body to grow uncontrollably. Chronic respiratory diseases are persistent health issues related to breathing that require ongoing management and treatment such as asthma or chronic obstructive pulmonary disorder (COPD). Diabetes mellitus is a metabolic disorder which affects the body's ability to produce or process insulin correctly resulting in high levels of sugar in the bloodstream and other side effects.

These conditions are interconnected by risk factors such as smoking, unhealthy diets, physical inactivity, and a lack of access to healthcare services that can prevent and treat them. Investing in public health research initiatives allows for better detection and monitoring tools for individuals at risk for developing chronic illnesses as well as improved treatments for those already suffering from them. Therefore, it is critical for low- and middle-income nations worldwide to prioritize health investments in order to reduce disability due to chronic illnesses and improve overall life expectancy rates across the globe.

Competitive Analysis

Over the projected period, rising emphasis on innovations and investments among public and private entities is expected to strengthen competition in the market. The key vendors in the global Intravenous Infusion Pumps market are Baxter International, B. Braun Melsungen, AG Medtronic, Micrel Medical Devices, SA Boston Scientific Corporation, CareFusion Corporation, Fresenius Kabi, and Smiths Medical among others.

Some of the recent development in the Intravenous Infusion Pumps Market are:

In April 2021, Medtronic announced the availability of its extended infusion set in several European countries. This infusion set may be worn for 7 days, allowing diabetic patients to continue intravenous infusion pump therapy with fewer insertions and interruptions.

In August 2020, Mindray released a new generation infusion system called the BeneFusion n Series. It provides significant insights into patient safety, interoperability and data management, and operational simplicity, all of which contribute to the establishment of new standards in infusion treatment.

To get extensive insights on key trends, request for customization here@ https://www.persistencemarketresearch.com/request-customization/33220

Market Segments Covered in Intravenous Infusion Pumps Industry Analysis

By Infusion Pumps Type

Volumetric Infusion Pumps
Insulin Infusion Pumps
Syringe Infusion Pumps
Enteral Infusion Pumps
Ambulatory Infusion Pumps
Patient-Controlled Analgesia Infusion Pumps
Implantable Infusion Pumps
Other Infusion Pumps Types

By Disease Indication

Chemotherapy
Diabetes
Gastroenterology
Analgesia/Pain Management
Pediatrics /Neonatology
Hematology
Other Disease Indications

By Region

North America
Latin America
Europe
APAC
MEA

Buy Full Report Now and Get Up to 20% Discount @ https://www.persistencemarketresearch.com/checkout/33220

Related Reports:

Telemedicine Market
https://www.persistencemarketresearch.com/market-research/telemedicine-market.asp

Robotic Surgery Market
https://www.persistencemarketresearch.com/market-research/robotic-surgery-market.asp

Veterinary Teleradiology Market
https://www.persistencemarketresearch.com/market-research/veterinary-teleradiology-market.asp

Dental Radiology Equipment Market
https://www.persistencemarketresearch.com/market-research/dental-radiology-equipment-market.asp

Contact us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City,
NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com

About Us:

Persistence Market Research is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. Persistence Market Research boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients' business needs.

This release was published on openPR.